KAS
ATRS

Kestra Advisory Services’s Antares Pharma, Inc. ATRS Stock Holding History

Kestra Advisory Services’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,264
Closed -$41K – 2233
2021
Q3 		$41K Hold
11,264
– – ﹤0.01% 2089
2021
Q2 		$49K Hold
11,264
– – ﹤0.01% 1979
2021
Q1 		$46K Sell
11,264
-2,986
-21% -$12.9K ﹤0.01% 1831
2020
Q4 		$57K Buy
+14,250
New +$46.1K ﹤0.01% 1811

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Kestra Advisory Services's ATRS Position: Q4 2021 in Review

Kestra Advisory Services sold out of Antares Pharma, Inc. (ATRS) in Q4 2021, closing a stake of 11,264 shares — an estimated $41K sold.

Kestra Advisory Services first reported a position in ATRS in Q4 2020 and held it in 4 quarters. The position peaked at $57K in Q4 2020. 162 funds tracked by Wall St. Rank hold ATRS as of Q4 2021.

  • Kestra Advisory Services reported no remaining Antares Pharma, Inc. position as of Q4 2021 after selling out during the quarter.
  • Kestra Advisory Services sold 11,264 Antares Pharma, Inc. shares in Q4 2021, an estimated $41K.
  • Kestra Advisory Services first reported a position in Antares Pharma, Inc. in Q4 2020 and held it in 4 quarters.
  • Kestra Advisory Services's Antares Pharma, Inc. position peaked at $57K in Q4 2020.
  • 162 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2021.

Based on Kestra Advisory Services's 13F filing for Q4 2021, filed 20 Jan 2022.